Association of PTTG1 expression with invasiveness of non-functioning pituitary adenomas

키워드

참고문헌 (45)

1. Gadelha MR, "Genetics of pituitary adenomas", Front Horm Res, 41, pp.111~140 (2013)
2. Greenman Y, "Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists", Eur J Endocrinol, 175, pp.63~72 (2016)
3. Greenman Y, "Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth", Clin Endocrinol(Oxf), 63, pp.39~44 (2005)
4. DeLellis RA, "World Health Organization classification of tumours : pathology and genetics of tumours of endocrine organs" (2004), IARC Press
5. Lloyd RV, "WHO cassification of tumours of endocrine organs" (2012), IARC Press
6. Saeger W, "Pathohistological classification of pituitary tumors : 10years of experience with the German Pituitary Tumor Registry", Eur J Endocrinol, 156, pp.203~216 (2007)
7. Zada G, "Atypical pituitary adenomas : incidence, clinical characteristics, and implications", J Neurosurg, 114, pp.336~344 (2011)
8. Scoazec JY, "Classification of pancreatic neuroendocrine tumours : changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future", Ann Pathol, 37, pp.444~456 (2017)
9. Trouillas J, "A new prognostic clinicopathological classification of pituitary adenomas : a multicentric casecontrol study of 410 patients with 8 years post-operative follow-up", Acta Neuropathol, 126, pp.123~135 (2013)
10. Matsuyama J, "Ki-67 expression for predicting progression of postoperative residual pituitary adenomas : correlations with clinical variables", Neurol Med Chir(Tokyo), 52, pp.563~569 (2012)
11. Chiloiro S, "Typical and atypical pituitary adenomas : a single-center analysis of outcome and prognosis", Neuroendocrinology, 101, pp.143~150 (2015)
12. Jee Soon Kim, "The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence", Journal of Pathology and Translational Medicine, 50(6), pp.419~425 (2016), 대한병리학회[DOI]
13. Mooney MA, "Rater reliability of the hardy classification for pituitary adenomas in the magnetic resonance imaging era", J Neurol Surg B Skull Base, 78, pp.413~418 (2017)
14. Thapar K, "p53 expression in pituitary adenomas and carcinomas : correlation with invasiveness and tumor growth fractions", Neurosurgery, 38, pp.765~770 (1996)
15. Oliveira MC, "Expression of p53 protein in pituitary adenomas", Braz J Med Biol Res, 35, pp.561~565 (2002)
16. Salehi F, "Biomarkers of pituitary neoplasms : a review(Part II)", Neurosurgery, 67, pp.1790~1798 (2010)
17. Sav A, "Biomarkers of pituitary neoplasms", Anticancer Res, 32, pp.4639~4654 (2012)
18. McCabe CJ, "Expression of pituitary tumour transforming gene(PTTG)and fibroblast growth factor-2(FGF-2)in human pituitary adenomas : relationships to clinical tumour behaviour", Clin Endocrinol(Oxf), 58, pp.141~150 (2003)
19. Shah PP, "Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin", Cancer Lett, 311, pp.66~76 (2011)
20. Zou H, "Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis", Science, 285, pp.418~422 (1999)
21. Salehi F, "Pituitary tumor-transforming gene in endocrine and other neoplasms : a review and update", Endocr Relat Cancer, 15, pp.721~743 (2008)
22. Feng W, "PTTG1cooperated with GLI1 leads to epithelial-mesenchymal transition in esophageal squamous cell cancer", Oncotarget, 8, pp.92388~92400 (2017)
23. Yoon CH, "PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population", J Biol Chem, 287, pp.19516~19527 (2012)
24. Nangia-Makker P, "Galectin-3 induces endothelial cell morphogenesis and angiogenesis", Am J Pathol, 156, pp.899~909 (2000)
25. Yoshii T, "Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest", J Biol Chem, 277, pp.6852~6857 (2002)
26. Cottier JP, "Cavernous sinus invasion by pituitary adenoma : MR imaging", Radiology, 215, pp.463~469 (2000)
27. Zhang X, "Pituitary tumor transforming gene(PTTG)expression in pituitary adenomas", J Clin Endocrinol Metab, 84, pp.761~767 (1999)
28. Raverot G, "Prognostic factors in prolactin pituitary tumors : clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up", J Clin Endocrinol Metab, 95, pp.1708~1716 (2010)
29. Li Y, "Relationship of PTTG expression with tumor invasiveness and microvessel density of pituitary adenomas : a meta-analysis", Genet Test Mol Biomarkers, 18, pp.279~285 (2014)
30. Trott G, "PTTG overexpression in non-functioning pituitary adenomas: Correlation with invasiveness, female gender and younger age", Ann Diagn Pathol, 41, pp.83~89 (2019)
31. Filippella M, "Pituitary tumour transforming gene(PTTG)expression correlates with the proliferative activity and recurrence status of pituitary adenomas : a clinical and immunohistochemical study", Clin Endocrinol(Oxf), 65, pp.536~543 (2006)
32. Noh TW, "Predicting recurrence of nonfunctioning pituitary adenomas", J Clin Endocrinol Metab, 94, pp.4406~4413 (2009)
33. Tamura R, "PITX2 expression in nonfunctional pituitary neuroendocrine tumor with cavernous sinus invasion", Endocr Pathol, 30, pp.81~89 (2019)
34. Acunzo J, "Inactivation of PITX2 transcription factor induced apoptosis of gonadotroph tumoral cells", Endocrinology, 152, pp.3884~3892 (2011)
35. Jin L, "Galectin-3 expression in functioning and silent ACTH-producing adenomas", Endocr Pathol, 16, pp.107~114 (2005)
36. Zhang Y, "The relationship between MRI invasive features and expression of EMMPRIN, galectin-3, and microvessel density in pituitary adenoma", Clin Imaging, 35, pp.165~173 (2011)
37. Righi A, "Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior", Hum Pathol, 44, pp.2400~2409 (2013)
38. Qian ZR, "Tumor-specific downregulation and methylation of the CDH13(H-cadherin)and CDH1(Ecadherin)genes correlate with aggressiveness of human pituitary adenomas", Mod Pathol, 20, pp.1269~1277 (2007)
39. Wong TS, "Interactions between E-cadherin and microRNA deregulation in head and neck cancers : the potential interplay", Biomed Res Int, 2014, pp.126038~ (2014)
40. Heaney AP, "Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis", Nat Med, 5, pp.1317~1321 (1999)
41. Wang Z, "Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes", Proc Natl Acad Sci U S A, 100, pp.3428~3432 (2003)
42. Mu YM, "Human pituitary tumor transforming gene(hPTTG)inhibits human lung cancer A549 cell growth through activation of p21(WAF1", CIP1), 2003, pp.50, 771~781
43. Yu R, "Murine pituitary tumor-transforming gene functions as a securin protein in insulinsecreting cells", J Endocrinol, 191, pp.45~53 (2006)
44. Dekkers OM, "The epidemiology of aggressive pituitary tumors(and its challenges)", Rev Endocr Metab Disord, 21, pp.209~212 (2020)
45. Roelfsema F, "Clinical factors involved in the recurrence of pituitary adenomas after surgical remission : a structured review and meta-analysis", Pituitary, 15, pp.71~83 (2012)

관련 논문AI추천